← Product Code [DQD](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQD) · K062364 # I-SCOPE 200 (K062364) _Dongjin Medical Co., Ltd. · DQD · Dec 6, 2006 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQD/K062364 ## Device Facts - **Applicant:** Dongjin Medical Co., Ltd. - **Product Code:** [DQD](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQD.md) - **Decision Date:** Dec 6, 2006 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1875 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The i-Scope 200 is intended for medical diagnostic purposes only. It can be used for the amplification of heart, lung and other body sounds with the use of selective frequency and can be used on any patient undergoing a physical assessment. ## Device Story i-Scope 200 is a digital stethoscope designed to amplify heart, lung, and other body sounds while filtering noise. It replaces traditional acoustic tubes with electronic amplification and selective frequency filtering. The device features soft earphone materials to improve comfort during long-term use. It is intended for use by healthcare professionals during physical assessments to aid in medical diagnosis. The device captures acoustic signals from the body, processes them electronically to enhance clarity and filter specific frequencies, and delivers the amplified sound to the clinician via earphones. This allows for improved auscultation compared to conventional stethoscopes, potentially facilitating more accurate diagnostic assessments. ## Clinical Evidence No clinical data provided; substantial equivalence is based on technological characteristics and intended use comparisons. ## Technological Characteristics Digital stethoscope; electronic amplification; selective frequency filtering; soft material earphone interface. Device operates as an electronic signal processing system for acoustic body sounds. ## Regulatory Identification Manual stethoscope: A mechanical device used to project the sounds associated with the heart, arteries, and veins and other internal organs. Electronic stethoscope: An electrically amplified device used to project the sounds associated with the heart, arteries, and veins and other internal organs. ## Special Controls *Classification.* Class II (special controls). The device, when it is a lung sound monitor, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. ## Predicate Devices - 3M Littmann Electronic stethoscope, Model 4000 ([K003723](/device/K003723.md)) - JABES electronic stethoscope ([K031446](/device/K031446.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K062364 #### DEC - 6 2006 510(k) SUMMARY Submission Information US Agent: Chong Kim 32936 Bluebird Loop Fremont, CA 94555 Official Correspondent: Min-Kang Kim 513-14, Sangdaewon-Dong, #1022 Sicox Tower, Chungwon-Ku, Sungnam-Si, Kyunggi-Do, Republic of Korea Sponsor: Dongjin Medical Co., Ltd. #1022 Sicox Tower, 513-14, Sangdaewon-Dong, Chungwon-Ku, Sungnam-Si, Kyunggi-Do, Republic of Korea Manufacturing Site Dongjin Medical Co., Ltd. 513-14, #1022 Sicox Tower, Sangdaewon-Dong, Chungwon-Ku, Sungnam-Si, Kyunggi-Do, Republic of Korea Device Identification Trade Name: i-Scope 200 Common Name: Digital Stethoscope Stethoscope per 21 CFR § 870.1875 Classification Name: Product Code: DQD The following 510(k) summary is being submitted as required by 21 CFR 807.92(a): # The subject device, i-Scope 200, is substantially equivalent in technical Substantially Equivalent Predicate Legally Marketed Devices - characteristics and intended used to: 3M Littmann Electronic stethoscope, Model 4000(K003723) - - JABES electronic stethoscope(K031446) - #### Device Description i-scope 200 digital stethoscope is a new advanced product compared to conventional stethoscopes that removes noise from tube of standard stethoscope. It dose not cause pain to the ear despite long-term use due to newly introduced soft materials applied in earphone. i-scope 200 digital stethoscope is intended for Page 1 of 2 {1}------------------------------------------------ medical diagnostic purposes only. It is used for the amplification of heart, lung and other body sounds with selective frequency filtering. This product is not designed, sold, or intended for any other use. #### Indications for Use The i-Scope 200 is intended for medical diagnostic purposes only. It can be used for the amplification of heart, lung and other body sounds with the use of selective frequency and can be used on any patient undergoing a physical assessment. ### Comparison to leally marketed predicate devices The i-Scope has the same intended use and similar technological characteristics as the predicate devices. Thus, the i-Scope is substantially equivalent to the predicate devices. Page 2 of 2 {2}------------------------------------------------ Public Health Service Image /page/2/Picture/11 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the symbol. The text is in all capital letters and is evenly spaced around the circle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC - 6 2006 Dongjin Medical Co., Ltd. c/o Min-Kang Kim Manager #1022 Sicox Tower, 513-514 Sangdaewon-Dong, Chungwon-Ku Sungnam-Si, Kyunggi-Do REPUBLIC OF KOREA 462-806 Re: K062364 Trade Name: I-Scope 200 Regulation Number: 21 CFR 870.1875 Regulation Name: Stethoscope Regulatory Class: II (two) Product Code: DQD Dated: October 11, 2006 Received: October 11, 2006 Dear Mr. Kim: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 – Mr. Min-Kang Kim Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Blumenthal for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use 510(k) Number (if known): Device Name: i-Scope 200 K062364 Indications for Use: The i-Scope 200 is intended for medical diagnostic purposes only. It can be used for the amplification of heart, lung and other body sounds with the use of selective frequency and can be used on any patient undergoing a physical assessment. B Zimmerman (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQD/K062364](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQD/K062364) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com